Prevalence of Nocturnal Hypoventilation in Obese Subjects Fiited With Continuous Positive Airway … (NCT07152990) | Clinical Trial Compass
Not Yet RecruitingNot Applicable
Prevalence of Nocturnal Hypoventilation in Obese Subjects Fiited With Continuous Positive Airway Pressure for Obstructive Sleep Apnea / Hypopnea Syndrome
France139 participantsStarted 2025-09
Plain-language summary
CAPNOSOH study is a single-center study conducted at Toulouse University Hospital, aiming to estimate the prevalence of obese and apneic subjects maintaining nocturnal hypoventilation under continuous positive airway pressure (CPAP).
Who can participate
Age range18 Years – 80 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria:
* Obese patients (Body Mass Index \> 30 kg/m2)
* Fitted by one of the following providers: ASTEN, Vitalaire, Orkyn, ISIS, RespiO2, BASTIDE for \> 3 months with compliance of more than 4 consecutive hours per night in average during 3 months
* "Good quality" criteria for continuous positive airway pressure (CPAP) treatment: compliance \> 4 consecutive hours per night, unintentional leaks \< limit defined by the manufacturer, residual AHI \< 10/h
* Aged 18 to 80
* Affiliated or beneficiaries of the social security system or equivalent
* Having given written informed consent
* Able to understand instructions and information given
Exclusion criteria :
* Patient under legal protection measure
* Non-compliant patients
* Pregnant or breast-feeding women (assessed on questioning)